Hodges Capital Management Inc.
Source: SEC Form 13F · as of Mar 2026Hodges Capital Management Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $39.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$39.4M
| Company | Shares | Value |
|---|---|---|
| HALOHALOZYME THERAPEUTICS, INC. | 134,696 | $8.7M |
| LLYELI LILLY & Co | 8,613 | $7.9M |
| ABBVAbbVie Inc. | 26,699 | $5.8M |
| JNJJOHNSON & JOHNSON | 19,435 | $4.8M |
| AMGNAMGEN INC | 8,424 | $3.0M |
| SOPHSOPHiA GENETICS SA | 435,836 | $2.2M |
| GMOptec International, Inc. | 28,439 | $2.1M |
| PMPhilip Morris International Inc | 11,950 | $2.0M |
| MRKMerck & Co., Inc. | 13,862 | $1.7M |
| GILDGILEAD SCIENCES, INC. | 8,718 | $1.2M |
| IBRXImmunityBio, Inc. | 10,000 | $77K |
| HURATuHURA Biosciences, Inc./NV | 10,000 | $18K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.